Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 933-939

  Konno, Hiroyuki ^a   Arai, Tomio ^b   Tanaka, Tatsuo ^a   Baba, Megumi ^a   Matsumoto, Keigo ^a   Kanai, Toshikazu ^a   Nakamura, Satoshi ^a   Baba, Shozo ^a   Naito, Yasuhisa ^a   Sugimura, Haruhiko ^a   Yukita, Ayako ^c   Asano, Makoto ^c   Suzuki, Hideo ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c Sanken Setsubi Kogyo Co   (Japan)

Author keywords

Angiogenesis; Endocrine neoplasm; Liver metastasis; VEGF; VEGFAb

Indexed keywords

NEUTRALIZING ANTIBODY; VASCULOTROPIN;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER TRANSPLANTATION; CASE REPORT; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031766832     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00651.x     Document Type: Article

References (34)

1. Creutzfeldt, W. and Stockmann, F. Carcinoids and carcinoid syndrome. Am. J. Med., 82, 4-16 (1987).
2. Bruine, A. P., Diejens, W. N. M., Pijls, M. M. J., Linden, E. P. M. v.d., Rousch, M. J. M., Moerkerk, P. T., de Goeij, A. F. P. M. and Bosman, F. T. NCI-H716 cells as a model for endocrine differentiation in colorectal cancer. Virchows Arch. B Cell Pathol., 62, 311-320 (1992).
3. Oberg, K. Endocrine tumors of the gastrointestinal tract: systemic treatment. Anticancer Drugs, 5, 503-519 (1994).
4. Tanaka, T., Konno, H., Matsuda, I., Nakamura, S. and Baba, S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res., 55, 836-839 (1995).
5. Konno, H., Tanaka, T., Kanai, T., Maruyama, K., Nakamura, S. and Baba, S. Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer, 77, 1736-1740 (1996).
6. Kanai, T., Konno, H., Tanaka, T., Matsumoto, K., Baba, M., Nakamura, S. and Baba, S. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice. Int. J. Cancer, 71, 838-841 (1997).
7. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S. and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patient. Cancer Res., 56, 2185-2190 (1996).
8. Kondo, S., Asano, M., Matsuo, K., Ohmori, I. and Suzuki, H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta, 1221, 211-214 (1994).
9. Arai, T. and Kino, I. Histochemical and ultrastructural analysis of glandular differentiation in typical carcinoid tumor of the hindgut. Pathol. Int., 44, 49-56 (1994).
10. Matui, K., Kitagawa, M., Miwa, A., Kuroda, Y. and Tsuji, M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am. J. Gastroenterol., 86, 1167-1175 (1991).
11. Kvols, L. K. and Buck, M. Chemotherapy of metastatic carcinoid and islet cell tumors. A review. Am. J. Med., 82, 77-83 (1987).
12. Ruszniewski, P., Rougier, P., Roche, A., Legmann, P., Sibert, A., Hochlaf, S., Ychou, M. and Mignon, M. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer, 71, 2624-2630 (1993).
13. Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Deucreux, M., Lasser, P., Elias, D. and Rougier, P. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology, 189, 541-547 (1993).
14. Chakravarthy, A. and Abrams, R. A. Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer, 75, 1386-1390 (1995).
15. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumor. Ann. Surg., 175, 409-416 (1972).
16. Folkman, J. What is the evidence that tumours are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4-6 (1990).
17. Ganen, Y. J., Launay, J. M., Debons-Guillemin, M. C., Lasneret, J., Roucayrol, A. M., Lesser, J., Peries, G. and Dreux, C. First heterotransplantation of a human carcinoid tumor into nude mice. Cancer, 68, 893-902 (1991).
18. Evers, B. M., Townsend, C. M., Jr., Upp, J. R., Allen, E., Hurlbut, C., Kim, S. W., Rajaraman, S., Singh, P., Reubi, J. C. and Thompson, J. C. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology, 101, 303-311 (1991).
19. Morikawa, K., Walker, S. M., Jessup, J. M. and Filder, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48, 1943-1948 (1988).
20. Fu, X., Besterman, J. M., Monosov, A. and Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA, 88, 9345-9349 (1991).
21. Leung, D.W., Cachianes, G., Kuang, W. J., Goeddel, D.V. and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309 (1989).
22. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science, 246, 1309-1312 (1989).
23. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R. and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53, 4727-4735 (1993).
24. Plate, K. H., Breier, G., Weich, H. A. and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848 (1992).
25. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991 (1992).
26. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D. and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586 (1992).
27. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R. and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor (KDR) correlates with vascularity, metastasis, and proliferation of colon cancer. Cancer Res., 55, 3964-3968 (1995).
28. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K. T., Manseau, E. J. and Dvorak, H. F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56, 172-181 (1996).
29. Dvorak, H. F., Brown, L. F., Detmar, M. and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-1039 (1995).
30. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S. and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844 (1993).
31. Asano, M., Yukita, A., Matsumoto, T., Kondo, S. and Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res., 55, 5296-5301 (1995).
32. Mandriota, S. J., Seghezzi, G., Vasalli, J. D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P. and Pepper, M. S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem., 1270, 9709-9716 (1995).
33. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95, 1789-1797 (1995).
34. Ahmed, M. H., Arai, T., Konno, H., Nahar, L., Tanaka, T., Izumiyama, N., Takubo, K., Nakamura, S. and Baba, S. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: occurrence of apoptosis and necrosis. Jpn. J. Cancer Res., 88, 977-981 (1997).